Amitraz is an active pharmaceutical ingredient with a molecular structure containing two aromatic rings and an amine group. It has been reported by the Environmental Protection Agency (EPA) to potentially cause developmental toxicity.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 33089-61-1
Humanin
pharmaceutical raw material
Betrixaban
pharmaceutical raw material
1-AMINOADAMATANE, 3-METHYL
pharmaceutical raw material
Zinc ascorbate
pharmaceutical raw material
N'-(2,4-dimethylphenyl)-N-[(2,4-dimethylphenyl)iminomethyl]-N-methylmethanimidamide
QXAITBQSYVNQDR-UHFFFAOYSA-N
CC1=CC(=C(C=C1)N=CN(C)C=NC2=C(C=C(C=C2)C)C)C